Hoppa till innehåll

Immunofibroblasts är avgörande drivkrafter för bildandet av tertiära lymfoida strukturer och lokal patologi

Saba Nayar, Joana Campos, Charlotte G Smith, Valentina Iannizzotto, David H Gardner, Frédéric Mourcin, David Roulois, Jason Turner, Marvin Sylvestre, Saba Asam, Bridget Glaysher, Simon J Bowman, Douglas T Fearon, Andrew Filer, Karin Tarte, Sanjiv A Luther, Benjamin A Fisher, Christopher D Buckley, Mark C Coles, Francesca Barone
Nyckelinsikter
  1. 01Fibroblaster kan omvandlas till specialiserade "immunofibroblaster"
  2. 02De bildar ett nätverk innan immunceller anländer
  3. 03Nätverket är avgörande för att upprätthålla inflammatoriska strukturer
  4. 04Att rikta in sig på dessa celler kan minska lokal vävnadsskada

Specialiserade fibroblaster bygger ett nätverk som är avgörande för de immunstrukturer som driver kronisk inflammation och lokal vävnadsskada.

Abstract

Resident fibroblasts at sites of infection, chronic inflammation, or cancer undergo phenotypic and functional changes to support leukocyte migration and, in some cases, aggregation into tertiary lymphoid structures (TLS). The molecular programming that shapes these changes and the functional requirements of this population in TLS development are unclear. Here, we demonstrate that external triggers at mucosal sites are able to induce the progressive differentiation of a population of podoplanin (pdpn)-positive stromal cells into a network of immunofibroblasts that are able to support the earliest phases of TLS establishment. This program of events, that precedes lymphocyte infiltration in the tissue, is mediated by paracrine and autocrine signals mainly regulated by IL13. This initial fibroblast network is expanded and stabilized, once lymphocytes are recruited, by the local production of the cytokines IL22 and lymphotoxin. Interfering with this regulated program of events or depleting the immunofibroblasts in vivo results in abrogation of local pathology, demonstrating the functional role of immunofibroblasts in supporting TLS maintenance in the tissue and suggesting novel therapeutic targets in TLS-associated diseases.

Citera denna studie
APA
Saba Nayar, Joana Campos, Charlotte G Smith, Valentina Iannizzotto, David H Gardner, Frédéric Mourcin, David Roulois, Jason Turner, Marvin Sylvestre, Saba Asam, Bridget Glaysher, Simon J Bowman, Douglas T Fearon, Andrew Filer, Karin Tarte, Sanjiv A Luther, Benjamin A Fisher, Christopher D Buckley, Mark C Coles, & Francesca Barone (2019). Immunofibroblasts är avgörande drivkrafter för bildandet av tertiära lymfoida strukturer och lokal patologi. https://fasciaresearchdatabase.com/immunofibroblasts-are-pivotal-drivers-of-tertiary-lymphoid-structure-formation-and-local-pathology/
MLA
Saba Nayar, et al. "Immunofibroblasts är avgörande drivkrafter för bildandet av tertiära lymfoida strukturer och lokal patologi." 2019, https://fasciaresearchdatabase.com/immunofibroblasts-are-pivotal-drivers-of-tertiary-lymphoid-structure-formation-and-local-pathology/.
Chicago
Saba Nayar et al. 2019. "Immunofibroblasts är avgörande drivkrafter för bildandet av tertiära lymfoida strukturer och lokal patologi.". https://fasciaresearchdatabase.com/immunofibroblasts-are-pivotal-drivers-of-tertiary-lymphoid-structure-formation-and-local-pathology/